Nurix
San Francisco, CA
Nurix, Inc. discovers and develops therapies. The Company develops small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.
nurixtx.comCompany Details
Founded
- 2012
Employees
- Between 200 - 500 employees
Raised
- $545,900,032
Headquarters Location
- San Francisco, CA
Public
- Yes
Acquired
- No
CEO
Arthur T. Sands
Founders
- Michael RapeJohn KuriyanArthur Weiss
Company Collections
These are collections Nurix is a part of. Click on the collection name to view similar companies.